Posted by Michael Wonder on 05 Dec 2018
Europe’s drug regulator is backing away from the U.K.
4 December 2018 - Potential split sparks concern about delays, patient access.
Europe’s medicines watchdog is bracing to make do without one of its most trusted partners.
The European Medicines Agency stopped assigning work to the U.K.’s pharmaceutical regulator earlier this year, unsure whether the two organisations will need to stop collaborating after Britain leaves the European Union in March. Preparing for a potential split, the EU body has also handed over responsibility for about 370 drugs that were overseen by the British authority to other countries.
